Proteomics

Dataset Information

0

EGF and Insulin combination dose and dynamic response of ERK, AKT, and mTOR signaling and the cell cycle (Cyclin D1) in serum- and growth-factor starved MCF10A cells.

ABSTRACT: MCF10A cells were seeded, allowed to attach overnight in full growth medium, serum-starved for ~24 hours, and then treated with the indicated compound(s) (EGF, Insulin and combinations) for the indicated amount of time (5, 30, 120, 360 min).

SUBMITTER: Birtwistle, M.; Iyengar, R.; Sobie, E. 

PROVIDER: LDS-1523 | LINCS | 2018-09-04

REPOSITORIES: LINCS

Json Xml

Dataset's files

Source:
Action DRS
DToxS&file=LDS-1523.tar.gz Other
DToxS&file=LDS-1524.tar.gz Other
DToxS&file=LDS-1525.tar.gz Other
DToxS&file=LDS-1526.tar.gz Other
Items per page:
1 - 4 of 4

Similar Datasets

Unknown Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Regulates Neurite Outgrowth Through the Activation of Akt/mTOR and Erk/mTOR Signaling Pathways.
| S-EPMC7541815 | biostudies-literature
Unknown Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway.
| S-EPMC3440333 | biostudies-literature
Unknown Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway.
| S-EPMC6872661 | biostudies-literature
Unknown C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells.
| S-EPMC5706898 | biostudies-literature
Unknown mTOR Activation by PI3K/Akt and ERK Signaling in Short ELF-EMF Exposed Human Keratinocytes.
| S-EPMC4592237 | biostudies-literature
Unknown <i>CSTB</i> accelerates the progression of hepatocellular carcinoma via the ERK/AKT/mTOR signaling pathway.
| S-EPMC10770458 | biostudies-literature
Unknown Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma.
| S-EPMC7416412 | biostudies-literature
Unknown Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.
| S-EPMC2518074 | biostudies-literature
Unknown Leukemia inhibitory factor (LIF) withdrawal activates mTOR signaling pathway in mouse embryonic stem cells through the MEK/ERK/TSC2 pathway.
| S-EPMC4816172 | biostudies-literature
Unknown EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
| S-EPMC4466682 | biostudies-literature